Index | MSCI USA Health Care |
Investment focus | Equity, United States, Health Care |
Fund size | GBP 492 m |
Total expense ratio | 0.12% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 11.58% |
Inception/ Listing Date | 12 September 2017 |
Distribution policy | Distributing |
Distribution frequency | Annually |
Fund domicile | Ireland |
Fund Provider | Xtrackers |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Custodial Services (Ireland) Limited |
Investment Advisor | DWS Investments UK Ltd |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Pricewaterhouse Coopers |
Fiscal Year End | 31 December |
Swiss representative | DWS CH AG |
Swiss paying agent | Deutsche Bank (Suisse) SA |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Eli Lilly & Co. | 12.19% |
UnitedHealth Group | 8.25% |
Johnson & Johnson | 6.48% |
Merck & Co., Inc. | 5.85% |
AbbVie, Inc. | 5.12% |
Thermo Fisher Scientific, Inc. | 4.03% |
Danaher Corp. | 3.29% |
Abbott Laboratories | 3.27% |
Amgen, Inc. | 2.98% |
Pfizer Inc. | 2.95% |
United States | 96.10% |
Ireland | 2.51% |
Other | 1.39% |
Health Care | 98.61% |
Other | 1.39% |
YTD | +9.22% |
1 month | +0.88% |
3 months | +4.60% |
6 months | +7.78% |
1 year | +11.54% |
3 years | +24.51% |
5 years | +70.91% |
Since inception (MAX) | +105.06% |
2023 | -3.63% |
2022 | +8.69% |
2021 | +26.43% |
2020 | +10.90% |
Current dividend yield | 1.16% |
Dividends (last 12 months) | GBP 0.55 |
Period | Dividend in GBP | Dividend yield in % |
---|---|---|
1 Year | GBP 0.55 | 1.28% |
2023 | GBP 0.53 | 1.17% |
2022 | GBP 0.71 | 1.66% |
2021 | GBP 0.36 | 1.07% |
2020 | GBP 0.37 | 1.20% |
Volatility 1 year | 11.58% |
Volatility 3 years | 16.65% |
Volatility 5 years | 19.80% |
Return per risk 1 year | 0.99 |
Return per risk 3 years | 0.46 |
Return per risk 5 years | 0.57 |
Maximum drawdown 1 year | -5.71% |
Maximum drawdown 3 years | -14.84% |
Maximum drawdown 5 years | -19.67% |
Maximum drawdown since inception | -19.67% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | XUHC | - - | - - | - |
Stuttgart Stock Exchange | EUR | XUHC | - - | - - | - |
London Stock Exchange | GBX | XSHC | XSHC LN XUHCEUIV | XSHC.L XUHCEURINAV=SOLA | |
London Stock Exchange | USD | XUHC | XUHC LN XUHCUSIV | XUHC.L XUHCUSDINAV=SOLA | |
SIX Swiss Exchange | USD | XUHC | XSHCGBIV | XSHCINAV=SOLA | |
SIX Swiss Exchange | CHF | XUHC | XUHC SW XSHCGBIV | XUHC.S XSHCINAV=SOLA | |
XETRA | EUR | XUHC | XUHC GY | XUHC.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 2,144 | 0.15% p.a. | Accumulating | Full replication |
iShares Nasdaq US Biotechnology UCITS ETF | 498 | 0.35% p.a. | Accumulating | Sampling |
SPDR S&P US Health Care Select Sector UCITS ETF | 364 | 0.15% p.a. | Accumulating | Full replication |
Invesco Nasdaq Biotech UCITS ETF | 324 | 0.40% p.a. | Accumulating | Swap-based |
Invesco US Health Care Sector UCITS ETF | 296 | 0.14% p.a. | Accumulating | Swap-based |